Post Profile

Crizotinib in bronchial carcinoma: New data not informative

(Institute for Quality and Efficiency in Health Care) After expiry of the limitation period, the manufacturer presented results from a later data cut-off. Due to frequent treatment switching, these cannot be interpreted in a meaningful way.
read more


Related Posts

Disease Management Programme Module On Heart Failure: Current Guidelines Indicate Some Need For Revision

Health : Medical News Today

On 14 February 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with heart failure. ...

Long Struggle For Appropriately Processed Manufacturer Data Leads To A New Assessment Of Memantine For Alzheimer's Disease

Health : Medical News Today

After the manufacturer of the Alzheimer's drug memantine submitted a supplementary analysis of study data, the German Institute for Quality and Efficiency in Health Care (IQWiG) sees proof of a benefit of the drug for cognitive func...

Ticagrelor after MI: Added benefit called into question by data subsequently submitted

Health : EurekAlert: Health

(Institute for Quality and Efficiency in Health Care) New analyses increased consistency and certainty of conclusions of the results on harmful aspects. Non-severe but clinically relevant bleeding also occurred more frequently under...

Bronchial carcinoma: Added benefit of crizotinib for first-line treatment not proven

Academics / General Science : Science Codex

The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have alr...

Allina Health researchers present LifeCourse findings national palliative care conference

Health : EurekAlert: Health

(Allina Health ) Allina Health researchers find that late life care can be sustainable and improve quality of life for patients, families and caregivers.


Copyright © 2016 Regator, LLC